Your browser doesn't support javascript.
loading
Resilient Older Subjects with Heterozygous Familial Hypercholesterolemia, Baseline Differences and Associated Factors.
Climent, Elisenda; González-Guerrero, Antón; Marco-Benedí, Victoria; García-Andreu, María-Del-Mar; Mediavilla-García, Juan Diego; Suárez-Tembra, Manuel; Benaiges, David; Pintó, Xavier; Pedro-Botet, Juan.
Afiliación
  • Climent E; Lipid and Vascular Risk Unit, Department of Endocrinology and Nutrition, Hospital del Mar, 08003 Barcelona, Spain.
  • González-Guerrero A; School of Medicine, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
  • Marco-Benedí V; Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Universidad de Zaragoza, 50009 Zaragoza, Spain.
  • García-Andreu MD; Hospital Ernest Lluch Martin, 50300 Calatayud, Spain.
  • Mediavilla-García JD; Vascular Risk Unit, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain.
  • Suárez-Tembra M; Lipid and Cardiovascular Risk Unit, Hospital San Rafael, 15006 A Coruña, Spain.
  • Benaiges D; Lipid and Vascular Risk Unit, Department of Endocrinology and Nutrition, Hospital del Mar, 08003 Barcelona, Spain.
  • Pintó X; Lipid and Cardiovascular Risk Unit, Department of Internal Medicine, Hospital Universitario de Bellvitge, 08907 Barcelona, Spain.
  • Pedro-Botet J; Lipid and Vascular Risk Unit, Department of Endocrinology and Nutrition, Hospital del Mar, 08003 Barcelona, Spain.
Int J Mol Sci ; 25(9)2024 Apr 29.
Article en En | MEDLINE | ID: mdl-38732050
ABSTRACT
Despite elevated low-density lipoprotein (LDL) cholesterol levels, some older subjects with heterozygous familial hypercholesterolemia (HeFH) do not develop atherosclerotic cardiovascular disease (ACVD) during their lifetime. The factors related to this resilient state have not been fully established. The aim of this study was to evaluate differential characteristics between older HeFH subjects with and without ACVD and factors associated with the presence of ACVD. Subjects were part of the Spanish Atherosclerosis Society Dyslipidemia Registry, and those ≥ 70 years old and with HeFH were included. Baseline characteristics of these subjects with and without ACVD were compared. A multivariate analysis was performed to assess factors associated with the presence of ACVD. A total of 2148 subjects with HeFH were included. Resilient subjects were mostly female, younger and presented fewer comorbidities with respect to the ACVD group. Subjects without ACVD had higher baseline high-density lipoprotein (HDL) cholesterol (55.8 ± 17.1 vs. 47.9 ± 15.4 mg/dL; p < 0.001) and lower lipoprotein(a) [Lp(a)] (53.4 ± 67.9 vs. 66.6 ± 85.6 mg/dL; p < 0.001) levels with respect to those in the ACVD group. Lp(a) and the presence of ≥3 risk factors were associated with the presence of ACVD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Heterocigoto / Hiperlipoproteinemia Tipo II Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Asunto principal: Heterocigoto / Hiperlipoproteinemia Tipo II Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Int J Mol Sci Año: 2024 Tipo del documento: Article País de afiliación: España